Showing results (141-150 of 334) with videos related to
Sort By:
Pageof 34
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|November 26, 1999
Occupational risk factors in Parkinson's diseaseJ K Tsui, D B Calne, Y Wang, et al.European Journal of Cancer Care|September 17, 2013
Can individual patients assess differences in quality of life between groups of patients?K Cocks, G Velikova, M T King, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1991
The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomographyB J Snow, M Bhatt, W R Martin, et al.Lancet (London, England)|August 2, 1986
Double-blind study of botulinum toxin in spasmodic torticollisJ K Tsui, A Eisen, A J Stoessl, et al.British Journal of Pharmacology|January 1, 1972
Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopaD B Calne, A Petrie, S Rao, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1986
The age of onset of Parkinson's disease: etiological implicationsH Teräväinen, L Forgach, M Hietanen, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1979
Treatment of Parkinson's disease with sodium valproate: clinical, pharmacological, and biochemical observationsJ Nutt, A Williams, C Plotkin, et al.Acta Neuropathologica|January 1, 1993
Further observations on Tau-positive glia in the brains with progressive supranuclear palsyT Yamada, D B Calne, H Akiyama, et al.Gut|March 1, 1973
Volatile fatty acids in the faeces of patients in 'germ-free' isolationD Gompertz, A P Brooks, H Gaya, et al.British Journal of Cancer|January 19, 2000
Sample size calculation for clinical trials: the impact of clinician beliefsP M Fayers, A Cuschieri, J Fielding, et al.Pageof 34